Tafenoquine combinations show promising parasite clearance in immunocompromised patients with babesiosis
60 Degrees Pharmaceuticals reports negative Babesia PCR tests in five patients receiving tafenoquine combinations, with FDA discussions planned.
Pharma & Biotech
Features & Analysis
Why Sixty Degrees Pharmaceuticals is betting on retail channels for tafenoquine adoption
Tafenoquine’s retail debut via GoodRx marks a shift in malaria prevention access. Find out what this means for U.S. travel medicine strategy.
Medical Devices & Diagnostics
Why 60 Degrees Pharmaceuticals is betting on Runway Health to reshape malaria prevention access
Discover how 60 Degrees Pharmaceuticals is using telehealth to expand ARAKODA access and what this shift means for malaria prevention strategy.